We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Neuropace
NPCE
$506M
| $99.8K | ﹤0.01% |
14,326
-338
| -2% | -$2.47K |
|
3202
Invivyd
IVVD
$218M
| $99.4K | ﹤0.01% |
97,424
+13,407
| +16% | +$14.5K |
|
3203
ASP Isotopes
ASPI
$558M
| $99.2K | ﹤0.01% |
35,699
-2,357
| -6% | -$6.26K |
|
|
ZK
3204
DELISTED
Zeekr
ZK
| $98.5K | ﹤0.01% |
4,420
+3,297
| +294% | +$55.9K |
|
3205
iQIYI
IQ
$1.28B
| $98.5K | ﹤0.01% |
34,443
| – | – |
|
|
MOR
3206
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $98.3K | ﹤0.01% |
5,187
| – | – |
|
3207
Vesta Real Estate
VTMX
$3.18B
| $97.3K | ﹤0.01% |
3,610
| – | – |
|
|
TI
3208
DELISTED
Telecom Italia
TI
| $97.2K | ﹤0.01% |
35,742
| – | – |
|
3209
The ONE Group
STKS
$53M
| $97.1K | ﹤0.01% |
26,400
-2,500
| -9% | -$10.1K |
|
|
MOND
3210
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $96.7K | ﹤0.01% |
69,584
+22,359
| +47% | +$47.3K |
|
3211
Kyverna Therapeutics
KYTX
$484M
| $96.7K | ﹤0.01% |
19,767
-240
| -1% | -$1.85K |
|
3212
Taylor Devices
TAYD
$175M
| $95.3K | ﹤0.01% |
1,909
-2
| -0.1% | -$103 |
|
3213
Sanara MedTech
SMTI
$313M
| $94.3K | ﹤0.01% |
3,119
-226
| -7% | -$7.05K |
|
3214
NLI Holdings
NL
$317M
| $93.6K | ﹤0.01% |
12,599
-280
| -2% | -$1.8K |
|
|
EEX
3215
DELISTED
Emerald Holding
EEX
| $93.4K | ﹤0.01% |
18,710
-12,492
| -40% | -$66.9K |
|
3216
Kaltura
KLTR
$267M
| $93.3K | ﹤0.01% |
68,640
-9,425
| -12% | -$11.6K |
|
3217
MINISO
MNSO
$3.75B
| $93.1K | ﹤0.01% |
5,306
| – | – |
|
|
RAPT
3218
DELISTED
RAPT Therapeutics
RAPT
| $92.8K | ﹤0.01% |
5,774
-40
| -0.7% | -$809 |
|
3219
Ultralife
ULBI
$106M
| $91.4K | ﹤0.01% |
10,107
-1,704
| -14% | -$17.6K |
|
3220
Empire Petroleum
EP
$111M
| $91.3K | ﹤0.01% |
17,384
+1,084
| +7% | +$5.58K |
|
|
MKTAY
3221
DELISTED
MAKITA CORP SPONS ADR
MKTAY
| $91.1K | ﹤0.01% |
2,698
+195
| +8% | +$6.59K |
|
3222
Porch Group
PRCH
$1.8B
| $90.9K | ﹤0.01% |
59,253
-5,994
| -9% | -$9.42K |
|
3223
Greenwich LifeSciences
GLSI
$211M
| $90.6K | ﹤0.01% |
6,302
-497
| -7% | -$7.36K |
|
|
MESO
3224
Mesoblast
MESO
$2.07B
| $90.3K | ﹤0.01% |
11,055
+829
| +8% | +$5.63K |
|
|
CLPR
3225
Clipper Realty
CLPR
$46.2M
| $90.3K | ﹤0.01% |
15,840
-228
| -1% | -$1.02K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.